Osteopathic Treatment vs Repositioning for Flat Head Syndrome
(OPT-IN Trial)
Trial Summary
What is the purpose of this trial?
The goal of this crossover randomized clinical trial is to assess the effects of osteopathic manipulative treatment (OMT) compared to standard of care repositioning in children diagnosed with positional/deformational plagiocephaly. The main hypothesis is that children who received OMT will show significantly improved anthropometric measures of cranial symmetry over those receiving the current pediatric standard of care of repositioning. This is a two-arm, randomized cross-over clinical trial. With parental consent, pediatric patients (infants \<4 months of age) will be organized into one of two groups: 1. Those who receive OMT with emphasis on osteopathic cranial manipulative medicine (OCMM) to restore cranial symmetry. 2. Those who receive standard care only with repositioning attention from the parents After 8-weeks of being in the first group, each participant will cross-over into the second group (OMT or repositioning) N = 122 subjects diagnosed with deformational plagiocephaly (DP) are to be recruited (to allow for natural attrition and loss to follow up) with the recruitment to continue until 61 patients have been placed in each of the two groups and will cross-over to the respective treatment group (OMT and standard of care repositioning therapy). Timeline: It is projected that to recruit and carry out the assessments and interventions (8-weeks of each group with 12-months of follow-up longitudinally), it will require two years (24-months) from the beginning of the study to completion.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications. Since the trial involves infants under 4 months of age, it's best to consult with the trial coordinators or your child's doctor for guidance.
What data supports the effectiveness of the treatment Osteopathic Manipulative Treatment (OMT) for Flat Head Syndrome?
Is osteopathic treatment generally safe for humans?
How is the treatment for flat head syndrome different from other treatments?
Research Team
Kimberly J Wolf, DO
Principal Investigator
Osteopathy's Promise to Children
Eligibility Criteria
This trial is for infants under 4 months old diagnosed with positional plagiocephaly, also known as flat head syndrome. It's not for those born preterm, with genetic syndromes, muscle tone disorders, craniofacial defects like cleft lip/palate, prior treatments such as helmet therapy or OMT, or other neurological issues.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment Phase 1
Participants receive either OMT or standard care repositioning for 8 weeks
Treatment Phase 2
Participants cross-over to the other treatment group (OMT or repositioning) for another 8 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Osteopathic Manipulative Treatment
- Standard of Care Repositioning
Osteopathic Manipulative Treatment is already approved in United States, European Union for the following indications:
- Positional plagiocephaly
- Deformational plagiocephaly
- Positional plagiocephaly
- Deformational plagiocephaly
Find a Clinic Near You
Who Is Running the Clinical Trial?
Osteopathy's Promise to Children
Lead Sponsor
Hollis King, DO
Collaborator